Work

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

Year: 2010

Type: article

Source: The Lancet

DOI: 10.1016/s0140-6736(10)60482-5

Authors: Angela Dispenzieri, Jerry A Katzmann, Robert A Kyle, Dirk R Larson, L Joseph Melton, Colin L Colby, Terry M Therneau, Raynell Clark, Shaji K Kumar, Arthur Bradwell, Rafael Fonseca, DF Jelinek, S Vincent Rajkumar

Institutions: Mayo Clinic, University of Birmingham, Mayo Clinic in Arizona

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: G1234102995, Rochester Epidemiology Project, G2018127191, G2269554244, G243382380, G3071120689, G3276378173, Angiogenesis and thalidomide therapy in multiple myeloma, G3710371131, SPORE in Multiple Myeloma, G6317171496, G7403876421, G7585679282, Studies on Monoclonal Gammopathies, G794485702, G8687299782, G918026202

OpenAlex ID: W2151638673

FWCI: 14.55

Cites: 36

Cited by: 394

Related to: 10